Gerald Lee, MD; Stanley Fineman, MD; Iris Otani, MD; Disclosures

Recorded 1/24/2025
AllergyWatch issue Nov/Dec 2024

To download the mp3 file, right click on the player and select Save audio as.

Interested in claiming CME for this episode? Click here

Show Notes

Welcome to another episode of Allergy Talk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma, and Immunology. For today’s episode we will be reviewing articles from Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.

Today we are joined by Dr. Iris Otani, an associate professor of medicine at UCSF and an assistant editor of Allergy Watch. We will be reviewing the November-December 2024 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.  

To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch. Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!

Articles Reviewed:

  1. Frequencies and predictors of subcutaneous and intraosseous injection with 4 epinephrine autoinjector devices
  2. Forecasting daily total pollen concentrations on a global scale
  3. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Speaker Disclosures back to top

Gerald Lee, MD
No relevant financial relationships with ineligible companies to disclose

Stanley Fineman, MD
Researcher: Novartis, Aimmune, DBV
Speaker: Genentech

Iris Otani, MD
Consultant: CSL Behring, Change Healthcare, Adivo Associates